dimiracetam

06/01/2014 - "Dimiracetam appears to be a promising and safe treatment for neuropathic pain conditions for which there are very limited therapeutic options. "
03/15/2008 - "Synthesis and biological evaluation of novel dimiracetam derivatives useful for the treatment of neuropathic pain."
06/01/2014 - "Broad spectrum and prolonged efficacy of dimiracetam in models of neuropathic pain."
12/13/2022 - "Pharmacological Profile of MP-101, a Novel Non-racemic Mixture of R- and S-dimiracetam with Increased Potency in Rat Models of Cognition, Depression and Neuropathic Pain."
09/01/2015 - "A model of neuropathic pain induced by sorafenib in the rat: Effect of dimiracetam."

12/13/2022 - "Similarly, acute oral administration of dimiracetam was more effective than a single enantiomer in the sodium monoiodoacetate (MIA) paradigm of painful osteoarthritis. "
06/01/2014 - "Acutely, dimiracetam was very effective in models of antiretroviral drug induced painful neuropathy, oxaliplatin-induced hyperalgesia and in the MIA-osteoarthritis. "

06/01/2014 - "Chronic dimiracetam dosing in the MIA and ART- induced models completely reverted hyperalgesia back to the level of healthy controls. "
06/01/2014 - "Acutely, dimiracetam was very effective in models of antiretroviral drug induced painful neuropathy, oxaliplatin-induced hyperalgesia and in the MIA-osteoarthritis. "

06/01/2014 - "Acutely, dimiracetam was very effective in models of antiretroviral drug induced painful neuropathy, oxaliplatin-induced hyperalgesia and in the MIA-osteoarthritis. "

12/13/2022 - "Based on the benign safety and tolerability profile previously observed with racemic dimiracetam, MP-101 appears to be a novel, promising clinical candidate for the prevention and treatment of several neuropathic and neurological disorders."